YorkSpace has migrated to a new version of its software. Access our Help Resources to learn how to use the refreshed site. Contact diginit@yorku.ca if you have any questions about the migration.
 

Child, parent, and service predictors of psychotropic polypharmacy among adolescents and young adults with an autism spectrum disorder

Simple item page
dc.contributor.authorLake, Johanna K.
dc.contributor.authorWeiss, Jonathan
dc.contributor.authorDergal, J.
dc.contributor.authorLunsky, Yona
dc.date.accessioned2017-06-20T20:00:38Z
dc.date.available2017-06-20T20:00:38Z
dc.date.issued2014-11
dc.description.abstractObjectives: This study examined the child, parent, and service factors associated with polypharmacy in adolescents and young adults with ASD. Methods: As part of an online survey examining health service utilization patterns among individuals with ASD, parents provided demographic and clinical information pertaining to their child. This included information on current medication use, as well as information on clinical services received, clinical history, and parent wellbeing. Analyses examined the bivariate association between individual child, parent, and service variables and polypharmacy. Variables significantly associated with polypharmacy were included in a multiple variable logistic regression. Results: Of the 363 participants sampled, approximately one quarter were receiving two or more psychotropic drugs concurrently. The child’s psychiatric co-morbidity, history of hurting others, therapy use, and parent burden were predictors of polypharmacy. Conclusion: Adolescents and young adults with ASD are a highly medicated population with multiple factors associated with psychotropic polypharmacy. While there may be circumstances where polypharmacy is necessary, a richer understanding of what predicts polypharmacy may lead to targeted interventions to better support these individuals and their families. Findings also highlight the need to support families of children with ASD prescribed multiple psychotropic medications.en_US
dc.description.sponsorshipThe Canadian Institutes of Health Research (funding reference number 102677) and the Centre for Addiction and Mental Health Postdoctoral Fellowship Award.
dc.identifier.citationJournal of Child and Adolescent Psychopharmacology, 24(9), 486-493.
dc.identifier.urihttps://doi.org/10.1089/cap.2014.0011en_US
dc.identifier.urihttp://hdl.handle.net/10315/33221
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Inc. publishersen_US
dc.rightsFinal publication is available from Mary Ann Liebert, Inc., publishers http://online.liebertpub.com/doi/abs/10.1089/cap.2014.0011en_US
dc.subjectautism spectrum disorderen_US
dc.subjectpolypharmacyen_US
dc.subjectpsychotropic medicationen_US
dc.subjectadolescentsen_US
dc.subjectyoung adultsen_US
dc.titleChild, parent, and service predictors of psychotropic polypharmacy among adolescents and young adults with an autism spectrum disorder
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Lake, Weiss, Dergal & Lunsky (2014).pdf
Size:
361.85 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.83 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Psychology

All items in the YorkSpace institutional repository are protected by copyright, with all rights reserved except where explicitly noted.